GBCS
Selectis Health, Inc.
$5.45
+0.24 (+4.61%)
At close · Jul 7
Going-concern doubt
— cleared May 22, 2026
The latest filing states the doubt was alleviated.
“As a result of the Company’s historical losses and projected cash needs, substantial doubt exists about the Company’s ability to continue as a going concern.”View the 10-Q filed May 22, 2026
Market Cap
$16.26M
Shares
3,067,059
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$41.44M
+4.9%
FY2025
Net Income
-$1.02M
+58.1%
FY2025
Operating Margin
-3.78%
+3.1pp
FY2025
Diluted EPS
-$0.34
+57.5%
FY2025
Operating Cash Flow
$1.88M
+203.2%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $38.24M | $41.44M | $39.49M | $36.78M | $40.6M | $29.29M | $20.93M | $6.93M | $3.62M | $3.13M | — | — | — | $3.14M | $5.15M | $5.52M | |
| — | $52.98K | $52.98K | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| $8.65M | $8.89M | $9.25M | $9.97M | $7.87M | $5.91M | $2.09M | $1.3M | $1.18M | $1M | $1.79M | $1.68M | $809.36K | $381.8K | $374.13K | $171.89K | |
| — | $16.74K | $103.43K | $347.78K | $315.98K | $157.29K | $121.94K | $26.93K | — | — | — | — | — | — | — | — | |
| — | $1.47M | $1.57M | $1.67M | $1.79M | $1.73M | $1.58M | $1.35M | — | — | — | — | — | $718.13K | $591.57K | $432.54K | |
| $40.65M | $43.01M | $42.22M | $45.74M | $40.89M | $30.02M | $17.55M | $5.63M | $3.28M | $2.67M | $2.92M | $4.75M | $2.51M | $3.15M | $5.57M | $6.79M | |
| -$2.41M | -$1.56M | -$2.73M | -$8.96M | -$286.57K | -$728.99K | $3.37M | $1.3M | $339.97K | $464.51K | -$57.68K | -$1.34M | -$652.38K | -$11.42K | -$416.89K | -$1.27M | |
| — | -3.78% | -6.91% | -24.36% | -0.71% | -2.49% | 16.13% | 18.77% | 9.38% | 14.84% | — | — | — | -0.36% | -8.09% | -23.03% | |
| — | -$90.25K | -$1.16M | -$7.29M | $1.51M | $1M | $4.96M | $2.65M | — | — | — | — | — | $706.71K | $174.67K | -$838K | |
| $2.11M | $1.73M | $2.05M | $2.17M | $2.23M | $2.5M | $2.14M | $2.14M | $2.14M | $2.21M | -$2.58M | -$2.81M | -$968.61K | $502.7K | $391.78K | $108.89K | |
| $8.98M | $549.72K | $305.24K | $4.99M | -$2.11M | -$1.51M | -$412.55K | $2.17M | $2.35M | $3.47M | $1.23M | $2.09M | -$2.12M | — | — | — | |
| — | -$1.01M | -$2.42M | — | — | — | — | — | — | — | — | — | — | -$1.81M | -$808.67K | -$1.38M | |
| — | $800 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| $6.17M | -$1.02M | -$2.42M | -$3.97M | -$2.4M | -$2.25M | $2.96M | -$861.61K | -$1.99M | -$3M | -$1.15M | -$3.33M | $1.36M | -$1.81M | -$808.67K | -$1.38M | |
| — | -2.45% | -6.14% | -10.8% | -5.9% | -7.69% | 14.12% | -12.43% | -54.98% | -95.74% | — | — | — | -57.59% | -15.69% | -25.01% | |
| — | — | — | — | — | $10.65K | $6554 | -$6417 | -$14.84K | -$5078 | -$140.86K | $45.5K | -$89.94K | $102.4K | — | — | |
| $6.14M | -$1.05M | -$2.45M | -$4M | -$2.43M | -$2.28M | $2.93M | -$891.61K | -$2.02M | -$3.03M | -$1.18M | -$3.36M | $1.31M | -$1.86M | -$865.6K | -$1.44M | |
| USD/shares | — | -$0.34 | -$0.80 | -$1.31 | -$0.79 | -$0.82 | $1.07 | -$0.30 | -$0.80 | -$1.20 | -$0.50 | -$1.50 | $0.70 | — | -$1.30 | — |
| USD/shares | — | -$0.34 | -$0.80 | -$1.31 | -$0.79 | -$0.82 | $0.95 | -$0.30 | -$0.80 | -$1.20 | -$0.50 | -$1.50 | $0.60 | — | -$1.30 | — |
| shares | — | 3.07M | 3.07M | 3.05M | 3.05M | 2.77M | 2.72M | 2.73M | 2.69M | 2.58M | 2.34M | 2.2M | 1.95M | 824.05K | 681.86K | — |
| shares | — | 3.07M | 3.07M | 3.05M | 3.05M | 2.77M | 3.11M | 2.73M | 2.69M | 2.58M | 2.34M | 2.2M | 2.2M | 824.05K | 681.86K | — |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2014–FY2020: $234.36K in buybacks, $855.39K in dividends.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
EV/EBIT
—
P/E (TTM)
2.98×
Medical Care Facilities median 16.79×
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | 2021-12-31 | 2020-12-31 |
|---|---|---|
| Health Care Services | $28,660,418 | $18,816,239 |
| Real Estate Services | $626,808 | $2,112,459 |
By Product & Service (USD)
| Component | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Health Care | $41,375,235 | $39,170,660 | $34,537,723 | $36,735,683 | $26,921,547 | $17,436,047 |
| Management Fee Revenue | $65,795 | — | — | — | $224,143 | — |
| Healthcare Grant Revenue | — | — | $1,610,754 | $3,272,026 | $1,514,728 | $1,380,192 |
| Health Care Revenue | — | — | — | — | — | $17,436,047 |
| Rental | — | $321,352 | $634,570 | $591,808 | $626,808 | $2,112,459 |
| Rental Revenue | — | — | — | — | — | $2,112,459 |
Segment Operating Income
Annual operating income by business segment, as tagged in the company's own XBRL filings. Segments need not sum to the consolidated figure — corporate costs and eliminations are typically unallocated.
By Segment (USD)
| Component | 2021-12-31 | 2020-12-31 |
|---|---|---|
| Health Care Services | $3,823,517 | $4,260,527 |
| Real Estate Services | -$4,552,509 | -$885,601 |
Operating Margin by Segment (%)
| Component | 2021-12-31 | 2020-12-31 |
|---|---|---|
| Health Care Services | 13.3% | 22.6% |
| Real Estate Services | -726.3% | -41.9% |